A broad range of Fab stabilities within a host of therapeutic IgGs

被引:193
作者
Garber, Ellen
Demarest, Stephen J.
机构
[1] Biogen Idec, Dept Prot Chem, San Diego, CA 92122 USA
[2] Biogen Idec, Dept Prot Engn, San Diego, CA 92122 USA
关键词
antibody humanization; immunoglobulin stability; protein folding; sequence consensus; germline;
D O I
10.1016/j.bbrc.2007.02.042
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although the functional properties of IgGs are well known, little has been published concerning the stability of whole IgG molecules. Stability is, however, a requirement for the development of antibodies For therapeutic or diagnostic applications. The hypervariable antigen-binding region (Fv) is responsible for stability variations between IgGs of identical subclass. To determine the range of stabilities that may be expected for human(ized) antibodies, differential scanning calorimetry was performed on 17 human(ized) antibodies from various in-house programs. The antigen-binding fragments (Fabs) of these antibodies exhibited thermal unfolding transitions with midpoints (T(M)s) varying from 57 to 82 degrees C. Antibodies with very low Fab stabilities were found to aggregate and express poorly. Fab instability was often associated with high levels of uncommonly observed amino acids or CDR loop lengths particularly within the variable heavy chain domain. Overall, the study provides a thermostability range for IgGs and suggests possible stability guidelines for developing antibody diagnostics or therapeutics. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:751 / 757
页数:7
相关论文
共 46 条
[11]   HUMAN IMMUNOGLOBULIN-VH AND IMMUNOGLOBULIN-VK REPERTOIRE REVEALED BY INSITU HYBRIDIZATION [J].
GUIGOU, V ;
CUISINIER, AM ;
TONNELLE, C ;
MOINIER, D ;
FOUGEREAU, M ;
FUMOUX, F .
MOLECULAR IMMUNOLOGY, 1990, 27 (09) :935-940
[12]   Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity [J].
Hoet, RM ;
Cohen, EH ;
Kent, RB ;
Rookey, K ;
Schoonbroodt, S ;
Hogan, S ;
Rem, L ;
Frans, N ;
Daukandt, M ;
Pieters, H ;
van Hegelsom, R ;
Coolen van Neer, N ;
Nastri, HG ;
Rondon, IJ ;
Leeds, JA ;
Hufton, SE ;
Huang, L ;
Kashin, I ;
Devlin, M ;
Kuang, GN ;
Steukers, M ;
Viswanathan, M ;
Nixon, AE ;
Sexton, DJ ;
Hoogenboom, HR ;
Ladner, RC .
NATURE BIOTECHNOLOGY, 2005, 23 (03) :344-348
[13]   Domain antibodies: proteins for therapy [J].
Holt, LJ ;
Herring, C ;
Jespers, LS ;
Woolven, BP ;
Tomlinson, IM .
TRENDS IN BIOTECHNOLOGY, 2003, 21 (11) :484-490
[14]   Selecting and screening recombinant antibody libraries [J].
Hoogenboom, HR .
NATURE BIOTECHNOLOGY, 2005, 23 (09) :1105-1116
[15]  
Hurle Mark R., 1994, Current Opinion in Biotechnology, V5, P428, DOI 10.1016/0958-1669(94)90053-1
[16]   One-megabase sequence analysis of the human immunoglobulin lambda gene locus [J].
Kawasaki, K ;
Minoshima, S ;
Nakato, E ;
Shibuya, K ;
Shintani, A ;
Schmeits, JL ;
Wang, J ;
Shimizu, N .
GENOME RESEARCH, 1997, 7 (03) :250-261
[17]   ANTIGEN-BINDING THERMODYNAMICS AND ANTIPROLIFERATIVE EFFECTS OF CHIMERIC AND HUMANIZED ANTI-P185HER2 ANTIBODY FAB FRAGMENTS [J].
KELLEY, RF ;
OCONNELL, MP ;
CARTER, P ;
PRESTA, L ;
EIGENBROT, C ;
COVARRUBIAS, M ;
SNEDECOR, B ;
BOURELL, JH ;
VETTERLEIN, D .
BIOCHEMISTRY, 1992, 31 (24) :5434-5441
[18]   Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides [J].
Knappik, A ;
Ge, LM ;
Honegger, A ;
Pack, P ;
Fischer, M ;
Wellnhofer, G ;
Hoess, A ;
Wölle, J ;
Plückthun, A ;
Virnekäs, B .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 296 (01) :57-86
[19]   ENGINEERED TURNS OF A RECOMBINANT ANTIBODY IMPROVE ITS IN-VIVO FOLDING [J].
KNAPPIK, A ;
PLUCKTHUN, A .
PROTEIN ENGINEERING, 1995, 8 (01) :81-89
[20]  
LEDER P, 1982, SCI AM, V246, P72